The Anti-inflammatory Effects of Leukotriene-Modifying Drugs and Their Use in Asthma
- 1 May 2001
- Vol. 119 (5) , 1533-1546
- https://doi.org/10.1378/chest.119.5.1533
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- The effect of zafirlukast on repetitive exercise–induced bronchoconstriction: The possible role of leukotrienes in exercise-induced refractorinessJournal of Allergy and Clinical Immunology, 1999
- Effects of ONO‐1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthmaClinical and Experimental Allergy, 1999
- Cytokines in asthmaThorax, 1999
- Prednisone-dependent asthma: inflammatory indices in induced sputumEuropean Respiratory Journal, 1999
- The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthmaClinical and Experimental Allergy, 1999
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- A Single Dose of Zafirlukast Reduces LTD4-Induced Bronchoconstriction in Patients on Maintenance Inhaled Corticosteroid TherapyAnnals of Allergy, Asthma & Immunology, 1998
- Effects of single-dose zileuton on bronchial hyperresponsiveness in asthmatic patients treated with inhaled corticosteroidsEuropean Respiratory Journal, 1997
- Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D 4–receptor antagonist cinalukastJournal of Allergy and Clinical Immunology, 1997
- Inhibition by a novel peptide leukotriene receptor antagonist ONO‐1078 of airway wall thickening and airway hyperresponsiveness to histamine induced by leukotriene C4 or leukotriene D4 in guinea‐pigsClinical and Experimental Allergy, 1994